Pro Share Advisors LLC Akero Therapeutics, Inc. Transaction History
Pro Share Advisors LLC
- $42.5 Billion
- Q4 2024
A detailed history of Pro Share Advisors LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 22,398 shares of AKRO stock, worth $1.01 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,398
Previous 16,921
32.37%
Holding current value
$1.01 Million
Previous $485,000
28.45%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding AKRO
# of Institutions
210Shares Held
74.3MCall Options Held
321KPut Options Held
558K-
Wellington Management Group LLP Boston, MA7.38MShares$334 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY6.86MShares$310 Million3.11% of portfolio
-
Janus Henderson Group PLC London, X06.03MShares$273 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$253 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$237 Million5.21% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.1B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...